Wire · regulatory
Treasury Draft Regulations Would Prohibit Certain U.S. Investments in Biotech Sector in China
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 3 November 2026 · Fusion42 review
The U.S. Treasury has proposed draft regulations under the COINS Act that would prohibit U.S. persons from investing in certain Chinese biotechnology sectors related to pharmaceutical compounds, automation, bio-manufacturing, and related technologies. The final rules are expected by March 13, 2027, and violations could result in penalties and divestment orders.
This Wire brief sits within Fusion42's coverage of Biotech, and 5 sources have reported it between 23 Oct 2026 and 3 Nov 2026.
◆ ◆ The Wire takeaway
You face imminent new rules banning investments in Chinese biotech linked to national security. Act fast to review all current or planned deals in this area and prepare to pivot away from China exposure by March 2027.
◆ Coverage
5 sources · first reported 23 Oct 2026 · latest 3 Nov 2026
◆ Related on Wire
◆ Topics